CATALOGO DEI PRODOTTI DELLA RICERCA

CALIÒ, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.504
NA - Nord America 3.653
AS - Asia 2.852
SA - Sud America 600
AF - Africa 85
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.707
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.565
RU - Federazione Russa 2.054
SG - Singapore 1.091
CN - Cina 901
GB - Regno Unito 819
BR - Brasile 488
IT - Italia 388
HK - Hong Kong 347
SE - Svezia 263
DE - Germania 249
IE - Irlanda 217
VN - Vietnam 205
FR - Francia 188
FI - Finlandia 118
KR - Corea 74
CA - Canada 49
AR - Argentina 46
UA - Ucraina 39
JP - Giappone 36
IN - India 35
NL - Olanda 33
ID - Indonesia 31
BE - Belgio 26
MX - Messico 25
BJ - Benin 23
PL - Polonia 23
IQ - Iraq 22
EC - Ecuador 21
ES - Italia 21
TG - Togo 21
TR - Turchia 19
AT - Austria 17
BD - Bangladesh 17
CO - Colombia 14
ZA - Sudafrica 14
LT - Lituania 10
VE - Venezuela 10
PY - Paraguay 9
SA - Arabia Saudita 9
AU - Australia 8
MA - Marocco 8
IR - Iran 7
CH - Svizzera 6
IL - Israele 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
BG - Bulgaria 4
PK - Pakistan 4
TN - Tunisia 4
TW - Taiwan 4
BH - Bahrain 3
CL - Cile 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
MK - Macedonia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
PS - Palestinian Territory 3
UZ - Uzbekistan 3
BO - Bolivia 2
CM - Camerun 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
LV - Lettonia 2
OM - Oman 2
SN - Senegal 2
UY - Uruguay 2
AI - Anguilla 1
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GF - Guiana Francese 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
ME - Montenegro 1
Totale 11.697
Salva come PNG Salva come JPEG
Città #
Southend 688
Moscow 661
Dallas 615
Singapore 448
Chandler 416
Hong Kong 338
Ashburn 330
Dublin 215
Beijing 184
Woodbridge 159
Jacksonville 148
Ann Arbor 138
The Dalles 124
Munich 87
Los Angeles 86
New York 80
Verona 76
Lawrence 68
Princeton 68
Wilmington 67
Ho Chi Minh City 63
Houston 61
Jinan 60
São Paulo 56
Redondo Beach 52
Helsinki 47
Shenyang 47
Columbus 44
Redmond 42
Santa Clara 39
London 38
Buffalo 37
Hanoi 35
Hebei 34
Tianjin 34
Nanjing 33
Milan 32
Sindelfingen 31
Tokyo 31
Rome 28
Seattle 27
Ningbo 26
Turku 25
Bologna 24
Changsha 24
Cotonou 23
Redwood City 22
Brussels 21
Lomé 21
Hangzhou 20
Nuremberg 20
Warsaw 19
Rio de Janeiro 18
Zhengzhou 18
Lancaster 17
Montreal 17
Seoul 17
Taizhou 17
Toronto 17
Brooklyn 16
Chennai 16
Amsterdam 15
Jakarta 15
Nanchang 15
Phoenix 15
Guangzhou 14
San Francisco 14
Belo Horizonte 13
Chicago 13
Orem 13
Stockholm 13
Taiyuan 13
Atlanta 12
Boston 12
Dearborn 12
Frankfurt am Main 12
Johannesburg 12
Madrid 12
Guayaquil 11
Baghdad 10
Denver 10
Fairfield 10
Haikou 10
Mexico City 10
Norwalk 10
Ankara 9
Biên Hòa 9
Boardman 9
Chongqing 9
Haiphong 9
Pozza 9
Shanghai 9
Da Nang 8
Fortaleza 8
Fuzhou 8
Meda 8
Poplar 8
Vienna 8
Washington 8
Bergamo 7
Totale 6.687
Salva come PNG Salva come JPEG
Nome #
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 214
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 214
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis 208
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 207
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 197
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 194
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 190
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 185
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 184
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 180
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 178
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 170
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 168
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 166
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 166
Pancolitis with ischemic injury as a complication of immunosuppressive treatment in a patient with autoimmune hepatitis: a case report. 158
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 157
Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung 150
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 149
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 148
A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss 146
Increased Frequency of Bronchiolar Histotypes in Lung Carcinomas Associated with Idiopathic Pulmonary Fibrosis 144
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 140
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 139
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 139
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 139
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 138
Primary Seminal Vesicle Carcinoma. The Usefulness of Pax8 Immunohistochemical Expression for the Differential Diagnosis 136
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 135
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 133
Multifocal Hepatic Angiosarcoma with Atypical Presentation: Case Report and Literature Review 132
2022-RA-1535-ESGO Uterine PEComa and prognostic value of the proposed classification systems: a retrospective study, systematic review, and metanalysis 130
From fine-needle aspiration cytology to fluorescent in-situ hybridization in an unusual case of pharyngeal synovial sarcoma 127
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 124
Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer? 121
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 121
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 119
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification 119
MiT family translocation renal cell carcinoma: looking for diagnostic and druggable markers 118
Recurrent primary endobronchial fetal rhabdomyoma: a case report and literature review 118
Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases 116
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 116
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 115
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour 113
Intestinal-type primary vaginal adenocarcinoma. Review of the literature with report of a case: from diagnosis to management 113
Histology and immunohistochemical evaluation of phimotic prepuce: The role of steroid therapy 112
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 111
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 111
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment 107
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 107
Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys 106
Renomedullary Interstitial Cell Tumors: Pathologic Features and Clinical Correlations 104
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 103
Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation 101
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 99
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 98
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 96
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 95
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022) 95
Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases 95
Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma 93
Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens 92
Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'? 90
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey 89
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 88
Robot-assisted excision of hemangioma of the right renal vein 86
♂♀ Mixed Epithelial and Stromal Tumors of the Kidney 85
Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre Study 85
Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press 85
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme 82
HER2 Aberrations in NSCLC: So Close Yet So Far 81
Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai 81
Small renal masses in young adults: Insights from a large contemporary multi-institutional Registry 80
Well-differentiated neuroendocrine tumor of the urinary bladder expressing GATA 3 79
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 79
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 79
Papillary Adenomas and Other Small Epithelial Tumors in the Kidney: An Autopsy Study 79
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 78
Determinants of oncologic outcomes in high-grade organ-confined prostate cancer after prostatectomy 77
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas 76
Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications 75
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 74
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 73
Pathological features and clinical associations of 58 small incidental angiomyolipomas of the kidney. 71
Uterine perivascular epithelioid cell tumors (PEComa) and the accuracy of proposed classification systems in predicting the malignant versus non-malignant behavior 67
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 64
Identification of diagnostic and predictive morphological and molecular markers in renal tumors 63
Patient Selection for Active Surveillance for Small Renal Masses: A Systematic Review of the Literature 63
Hot topics in renal cancer pathology: implications for clinical management 62
SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation 58
Histology for nephrology, from pre-implantation to post-transplant kidney biopsy. Lesson learned from ReBIrth (Renal BIopsy for Kidney Transplantation Therapy) 58
A modified Delphi consensus statement on the role of biopsy in small renal masses 58
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 57
Interleukin-8 as a potential prognostic biomarker in Renal Cell Carcinoma: A systematic review and Meta-Analysis 57
Oncocytoma on renal mass biopsy: why is surgery even performed? 56
WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist 56
Multitarget Fluorescence in Situ Hybridization diagnostic applications in solid and hematological tumors 55
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 54
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations 54
TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum 52
Totale 11.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.576
article - articoli 40.862
book - libri 0
conference - conferenze 933
curatela - curatele 0
other - altro 501
patent - brevetti 0
selected - selezionate 0
volume - volumi 280
Totale 85.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021279 0 0 0 0 0 79 29 19 18 31 67 36
2021/2022598 65 151 3 69 29 26 17 37 20 14 42 125
2022/20231.260 80 134 105 220 99 330 19 65 130 21 33 24
2023/2024786 35 55 73 73 88 127 42 54 22 48 122 47
2024/20252.415 124 136 185 319 93 76 128 96 313 231 268 446
2025/20264.807 508 451 724 1.223 1.826 75 0 0 0 0 0 0
Totale 12.001